United States· US:70518-3915_3ba26cb7-32e1-5652-e063-6394a90a3692
Diphenoxylate Hydrochloride and Atropine Sulfate
A belladonna alkaloids, tertiary amines product containing diphenoxylate hydrochloride and atropine sulfate, registered in United States by REMEDYREPACK INC..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- diphenoxylate hydrochloride and atropine sulfate
- Manufacturer
- REMEDYREPACK INC.
- Country
- United States (US)
- ATC code
- A03BA
- ATC class
- Belladonna alkaloids, tertiary amines
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 1
- ndc11705183915130 TABLET in 1 BLISTER PACK (70518-3915-1)
Regulatory notes
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e2770c8b-1126-4891-955c-fe008edbf6aa GET /v1/drugs/e2770c8b-1126-4891-955c-fe008edbf6aa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "03J5ZE7KA5",
"rxcui": "153971",
"inchikey": "JPKKQJKQTPNWTR-WFEZVHBLSA-N;JPKKQJKQTPNWTR-AAWIVWGASA-N",
"display_name": "ATROPINE SULFATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"bd08ed90-dd26-4629-83c0-0f75af6ebb95": {
"match": "brand_token",
"title": "DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE TABLET [BRYANT RANCH PREPACK]",
"spl_version": "8",
"published_date": "2026-05-25"
}
},
"productid": "70518-3915_3ba26cb7-32e1-5652-e063-6394a90a3692",
"productndc": "70518-3915",
"dosage_form": "TABLET",
"orange_book": {
"appl_no": "213413",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AA",
"strength": "0.025MG;2.5MG",
"product_no": "001",
"approval_date": "Feb 20, 2020"
}
],
"appl_type": "A"
},
"dea_schedule": "CV",
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE",
"shortage_reason": "Atropine Sulfate Injection",
"shortage_status": "current",
"proprietary_name": "Diphenoxylate Hydrochloride and Atropine Sulfate",
"active_ingred_unit": "mg/1; mg/1",
"application_number": "ANDA213413",
"marketing_category": "ANDA",
"nonproprietary_name": "diphenoxylate hydrochloride and atropine sulfate",
"start_marketing_date": "20231116",
"active_numerator_strength": ".025; 2.5"
}See everything about diphenoxylate hydrochloride and atropine sulfate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.